Reply to the Letter to the Editor by Hughes in response to the article entitled “Multicentre randomised Phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced NSCLC”, published in vol. 41 Issue 1 of the European Journal of Cancer

✍ Scribed by Andrea Martoni; Lorenzo Mantovani

• Book ID: 116428533
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 66 KB
• Volume: 41
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2005.02.032